A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Solid Tumor, Adult
Interventions: DRUG: APG-2575|DRUG: Palbociclib
Sponsor: Ascentage Pharma Group Inc.